Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Equities
603707
CNE100002WP3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.47 CNY | -3.45% |
|
-6.75% | -23.53% |
07-01 | Nanjing King-Friend Biochemical Pharma Registers Regadenoson Injection in China; Shares Up 3% | MT |
06-28 | NKFPharma's Unit Buys Yusimry's Rights for $40 Million | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.53% | 2.54B | |
+54.07% | 809B | |
+37.66% | 621B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.11% | 238B | |
-1.72% | 221B | |
+14.13% | 218B | |
+7.42% | 166B |
- Stock Market
- Equities
- 603707 Stock
- News Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
- Nanjing King-Friend Biochemical Pharma Registers Regadenoson Injection in China; Shares Up 3%